1.
GENDER-BASED ANALYSIS OF ADVERSE EFFECTS OF DAPAGLIFLOZIN AND EMPAGLIFLOZIN IN CHRONIC KIDNEY DISEASE ASSOCIATED WITH TYPE 2 DIABETES: A COMPARATIVE . GSR. 2025;2(1):418-422. Accessed November 16, 2026. https://global-science-review.com/ojs/index.php/gsr/article/view/238